Description

FEXY SUSPENSION 60ML

Indications

FEXY SUSPENSION 60ML is primarily indicated for the treatment of allergic rhinitis, including seasonal and perennial forms. It is also effective in managing symptoms associated with chronic urticaria, such as itching and hives. The formulation is suitable for adults and children above a certain age, making it a versatile option for those suffering from allergic reactions.

Mechanism of Action

The active ingredient in FEXY SUSPENSION is fexofenadine, an antihistamine that works by selectively inhibiting peripheral H1 receptors. By blocking these receptors, fexofenadine reduces the effects of histamine, a substance in the body that causes allergic symptoms. This action alleviates symptoms such as sneezing, runny nose, itchy or watery eyes, and itching of the throat or nose. Unlike some first-generation antihistamines, fexofenadine does not readily cross the blood-brain barrier, which minimizes sedation and central nervous system effects.

Pharmacological Properties

Fexofenadine is classified as a second-generation antihistamine. Its pharmacokinetics indicate that it is rapidly absorbed, with peak plasma concentrations occurring approximately 2-3 hours after oral administration. The bioavailability of fexofenadine is approximately 40%, and it has a half-life of about 14.4 hours, allowing for once or twice daily dosing. Fexofenadine is primarily excreted unchanged in the feces and urine, with minimal metabolism occurring in the liver, making it a suitable option for patients with hepatic impairment.

Contraindications

FEXY SUSPENSION is contraindicated in individuals with known hypersensitivity to fexofenadine or any of the excipients in the formulation. Caution should be exercised in patients with severe renal impairment, as the pharmacokinetics of fexofenadine may be altered in this population. Additionally, it is not recommended for use in patients with a history of anaphylactic reactions to antihistamines.

Side Effects

Common side effects associated with FEXY SUSPENSION may include headache, dizziness, drowsiness, and gastrointestinal disturbances such as nausea or diarrhea. Serious side effects are rare but may include allergic reactions, such as rash, itching, or swelling. Patients should be advised to report any severe or persistent side effects to their healthcare provider. Overall, the incidence of side effects is lower compared to first-generation antihistamines, making fexofenadine a preferred choice for many patients.

Dosage and Administration

The recommended dosage of FEXY SUSPENSION for adults and children aged 12 years and older is 60 mL once daily. For children aged 6 to 11 years, the dosage may be adjusted based on body weight and clinical response, typically ranging from 30 mL to 60 mL once daily. It is important to shake the suspension well before use and measure the dose accurately using a dosing syringe or cup. Patients should be instructed to take the medication with water and avoid taking it with fruit juices, as this may affect absorption.

Interactions

Fexofenadine has a low potential for drug interactions due to its minimal metabolism by the liver. However, co-administration with certain medications, such as ketoconazole or erythromycin, may increase plasma concentrations of fexofenadine. Patients should inform their healthcare provider about all medications they are currently taking, including over-the-counter drugs and herbal supplements, to avoid potential interactions. Additionally, the use of fexofenadine with alcohol should be approached with caution, as it may enhance the sedative effects of alcohol.

Precautions

Patients with a history of renal impairment should use FEXY SUSPENSION with caution, as dosage adjustments may be necessary. It is also advisable for patients with cardiovascular conditions to consult their healthcare provider before starting treatment, as antihistamines may have cardiovascular effects in some individuals. Pregnant and breastfeeding women should discuss the risks and benefits of using fexofenadine with their healthcare provider, as safety in these populations has not been fully established.

Clinical Studies

Clinical studies have demonstrated the efficacy of fexofenadine in reducing symptoms of allergic rhinitis and chronic urticaria. In a randomized, double-blind, placebo-controlled trial, patients receiving fexofenadine reported significant improvements in nasal symptoms compared to those receiving a placebo. Another study highlighted the safety profile of fexofenadine, showing that it was well-tolerated among participants with minimal adverse effects. These findings support the use of FEXY SUSPENSION as an effective treatment option for allergic conditions.

Conclusion

FEXY SUSPENSION 60ML is a well-established antihistamine that provides effective relief from allergic rhinitis and chronic urticaria symptoms. Its favorable pharmacological properties, low incidence of side effects, and minimal drug interactions make it a suitable choice for a wide range of patients. As with any medication, it is essential for patients to follow their healthcare provider’s instructions and report any concerning symptoms or side effects during treatment.